Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

António E Pinto

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Expert Review of Molecular Diagnostics|October 13, 2009
Clinical implications of molecular markers in follicular cell-derived thyroid cancerAntónio E Pinto, Valeriano Leite, Jorge Soares
Acta Medica Portuguesa|November 5, 2004
[DNA flow cytrometry in solid tumors]António E Pinto, Isabel Fonseca, Jorge Soares
Oncology Reports|September 3, 2009
Underexpression of PPARgamma is associated with aneuploidy and lower differentiation of thyroid tumours of follicular originCarla Espadinha, António E Pinto, Valeriano Leite
Virchows Archiv : an International Journal of Pathology|June 7, 2014
Fibromatosis-like metaplastic carcinoma of the breast has a claudin-low immunohistochemical phenotypeMiguel Rito, Fernando Schmitt, António E Pinto, et al.
Pathology|May 7, 2005
Correlations of cell cycle regulators (p53, p21, pRb and mdm2) and c-erbB-2 with biological markers of proliferation and overall survival in breast cancerAntónio E Pinto, Saudade André, Cátia Laranjeira, et al.
Breast (Edinburgh, Scotland)|April 30, 2015
Aneuploidy identifies subsets of patients with poor clinical outcome in grade 1 and grade 2 breast cancerAntónio E Pinto, Teresa Pereira, Giovani L Silva, et al.
Diagnostic Cytopathology|September 25, 2003
Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphomaAntónio E Pinto, José Cabeçadas, Sónia D Nóbrega, et al.
Oncology Letters|April 30, 2017
Prognostic relevance of DNA flow cytometry in breast cancer revisited: The 25-year experience of the Portuguese Institute of Oncology of LisbonAntónio E Pinto, Teresa Pereira, Giovani L Silva, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|September 1, 2006
DNA flow cytometry but not telomerase activity as predictor of disease-free survival in pT1-2/N0/G2 breast cancerAntónio E Pinto, Saudade André, Teresa Pereira, et al.
Oncology Reports|September 25, 2008
Aneuploidy and high S-phase as biomarkers of poor clinical outcome in poorly differentiated and anaplastic thyroid carcinomaAntónio E Pinto, Giovani Silva, Ana Banito, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Expert Review of Molecular Diagnostics|October 13, 2009
Clinical implications of molecular markers in follicular cell-derived thyroid cancerAntónio E Pinto, Valeriano Leite, Jorge Soares
Acta Medica Portuguesa|November 5, 2004
[DNA flow cytrometry in solid tumors]António E Pinto, Isabel Fonseca, Jorge Soares
Oncology Reports|September 3, 2009
Underexpression of PPARgamma is associated with aneuploidy and lower differentiation of thyroid tumours of follicular originCarla Espadinha, António E Pinto, Valeriano Leite
Virchows Archiv : an International Journal of Pathology|June 7, 2014
Fibromatosis-like metaplastic carcinoma of the breast has a claudin-low immunohistochemical phenotypeMiguel Rito, Fernando Schmitt, António E Pinto, et al.
Pathology|May 7, 2005
Correlations of cell cycle regulators (p53, p21, pRb and mdm2) and c-erbB-2 with biological markers of proliferation and overall survival in breast cancerAntónio E Pinto, Saudade André, Cátia Laranjeira, et al.
Breast (Edinburgh, Scotland)|April 30, 2015
Aneuploidy identifies subsets of patients with poor clinical outcome in grade 1 and grade 2 breast cancerAntónio E Pinto, Teresa Pereira, Giovani L Silva, et al.
Diagnostic Cytopathology|September 25, 2003
Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphomaAntónio E Pinto, José Cabeçadas, Sónia D Nóbrega, et al.
Oncology Letters|April 30, 2017
Prognostic relevance of DNA flow cytometry in breast cancer revisited: The 25-year experience of the Portuguese Institute of Oncology of LisbonAntónio E Pinto, Teresa Pereira, Giovani L Silva, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|September 1, 2006
DNA flow cytometry but not telomerase activity as predictor of disease-free survival in pT1-2/N0/G2 breast cancerAntónio E Pinto, Saudade André, Teresa Pereira, et al.
Oncology Reports|September 25, 2008
Aneuploidy and high S-phase as biomarkers of poor clinical outcome in poorly differentiated and anaplastic thyroid carcinomaAntónio E Pinto, Giovani Silva, Ana Banito, et al.
Pageof 3